Hook / Thesis
Viavi Solutions has stopped being a turnaround story and is beginning to show the kind of margin and cash-flow improvement that justifies re-rating. The company reported a strong fiscal Q4 where revenue jumped 52.5% to $443.1 million and adjusted EPS rose 161.5% to $0.34, and management guided Q1 revenue to $450-460 million with non-GAAP EPS of $0.40-0.42. Those numbers matter because they signal that higher-value testing and assurance work - much of it tied to AI-data-center buildouts - is shifting the mix toward higher margins.
At a current price of $38.75 and a market capitalization near $9.56 billion, Viavi's valuation begins to look more attractive when you factor in accelerating profit growth, a growing free cash flow stream (recent free cash flow was $82.8 million), and a manageable balance sheet (debt/equity ~0.44). This is a tradeable long with a clear entry, stop, and target for a mid-term swing.
What the business does and why the market should care
Viavi provides network test, monitoring and assurance solutions and also sells optical components used across anti-counterfeiting, 3D sensing, aerospace and industrial markets. Its two operating segments - Network and Service Enablement (NSE) and Optical Security and Performance - give Viavi exposure to both telecom/datacom infrastructure and specialty optical markets.
The practical takeaway for investors: as cloud and hyperscale operators ramp AI infrastructure, they demand more optical capacity and more sophisticated test and assurance tools. Management said AI data centers now account for roughly half of NSE segment revenues. That structural tailwind drives higher ASPs (average selling prices) for test equipment and recurring software/assurance revenue, which boosts margins and cash flow much faster than a commodity hardware cycle.
Evidence: growth, margins and cash
- Fiscal Q4 revenue: $443.1 million, up 52.5% year-over-year.
- Q4 non-GAAP EPS: $0.34, up 161.5% year-over-year.
- Recent quarter (Q3 reported earlier) showed $406.8 million revenue, up 42.8% YoY, confirming momentum into Q4.
- Guidance for Q1: revenue $450-460 million and non-GAAP EPS $0.40-0.42, signaling continued sequential strength.
- Free cash flow: $82.8 million (most recent available), supporting both acquisition optionality and internal investment.
Those numbers are not one-off blips. Margins improved materially, and the company is converting revenue growth into earnings and cash. The Spirent acquisition and a stronger aerospace/defense book add optionality for margin expansion and cross-selling.
Valuation framing
At $38.75 the market cap sits around $9.56 billion and enterprise value is roughly $9.56 billion as well (EV reported at $9.555B). The reported price-to-sales ratio is ~6.3x and EV/EBITDA is ~41.7x. Those multiples look rich on the surface versus legacy networking names, but two factors mitigate that: first, Viavi is in a rapid re-rating phase driven by above-market revenue growth (recent quarterly growth in the 40-50% range); second, the company's profile is shifting from lower-margin, cyclical equipment to higher-margin test, monitoring and software/assurance revenue tied to data-center and AI rollout.
Free cash flow of $82.8 million and a modest net leverage (debt/equity ~0.44) mean Viavi is not funding growth with aggressive leverage. The trailing P/E appears negative on a GAAP basis, but adjusted earnings are improving quickly - management now guiding to non-GAAP EPS in the $0.40s for the coming quarter. If Viavi sustains the current revenue run-rate (recent quarters imply a run-rate around $1.7-1.8 billion annualized based on the latest quarter), multiple compression risk recedes and the current valuation becomes reasonable for a company growing revenue and profits above most peers.
Catalysts (2-5)
- Near-term: Q1 results and guidance (management guided $450-460M and $0.40-0.42 EPS) - a beat would likely re-accelerate multiple expansion.
- AI/data-center capex cycle sustaining a multi-quarter ramp in optical testing demand - large cloud customers already make up a meaningful portion of NSE revenue.
- Integration and cross-sell benefits from the Spirent-related strategic moves; any announced synergies or design wins in hyperscale customers would be positive.
- Broader optical market strength (as seen in peers reporting strong orders/backlogs) that supports backlog growth and pricing stability.
Trade plan (actionable)
Thesis: buy a mid-term swing to capture continued revenue and profit momentum and the re-rating of the multiple as adjusted EPS and free cash flow improve.
| Entry | Target | Stop | Horizon |
|---|---|---|---|
| $38.75 | $48.00 | $34.00 | Mid term (45 trading days) |
Rationale: Entry at $38.75 matches the current quote and provides an opportunity to capture momentum following recent beats and guidance. The $48.00 target implies roughly a 24% upside and corresponds to modest multiple expansion as adjusted EPS continues to improve and the street re-assesses long-term margins. The $34.00 stop limits downside to about 12% and sits below the recent consolidation range and near the 50-day moving average area; a break there would suggest the acceleration thesis is failing.
Expect to hold the position for up to 45 trading days to allow time for catalysts - quarterlies, guidance confirmations, and data-center order flow - to materialize. If the company consistently beats and guidance tightens higher, consider extending the horizon to capture further re-rating.
Risks and counterarguments
- Demand pullback: AI/data-center spending could slow or be pushed out by customers, which would reduce high-margin NSE bookings and compress near-term results. A meaningful slowdown would invalidate the re-rating and could push the stock back to previous trading multiples.
- Valuation sensitivity: At EV/EBITDA ~41.7x and P/S ~6.3x, expectations are embedded. Any miss on guidance or margins would cause sharp multiple contraction because the current price already reflects aggressive growth assumptions.
- Supply chain or execution risk: Optical components and test equipment manufacturing can be subject to lead-time issues and component shortages. Execution delays or cost inflation could pressure margins and delivery schedules.
- Competition and pricing: Large peers are also benefiting from optical demand; increased competitive intensity could limit ASP improvements or lead to pricing pressure on certain product lines.
- Macro/capex cycles: A broad tech capex pullback or recessionary environment would hit spending on big network upgrades and could reduce multi-quarter order flow visibility.
Counterargument: A reasonable counter view is that the market has already priced in the best-case revenue trajectory for Viavi. The stock's multiples are high, and if growth slows even modestly, downside could be swift. This trade assumes continued strong execution and that the company converts revenue growth into durable margin improvement; if that conversion stalls, the thesis fails.
What would change my mind
I would reconsider the bullish stance if any of the following occur: (1) management cuts near-term guidance or withdraws forward-looking commentary, (2) reported margins decelerate or free cash flow turns negative due to execution issues, (3) customers (hyperscalers/cloud providers) publicly announce significant capex slowdowns or delays, or (4) material integration issues or unexpected dilution from acquisitions. Conversely, sustained beats, an upgrade to full-year guidance, or public design wins at major cloud customers would strengthen the bull case and justify adding size or extending the horizon.
Bottom line
Viavi is a tactical buy for a mid-term swing. The combination of 40-50% quarterly revenue growth, accelerating non-GAAP EPS, improving free cash flow and a modestly leveraged balance sheet makes the current entry around $38.75 a reasonable risk/reward. The stock is not cheap on headline multiples, so this trade depends on continued execution and confirmation of management's guidance. If those conditions hold over the next 45 trading days, the path to $48 looks credible; miss those markers and discipline to the $34 stop is the prudent play.
Important: This trade plan is a directional idea tied to near-term execution and sector momentum. Manage position size relative to portfolio risk tolerance.